The love score
These days oncology drugs often have similar profiles. How an oncologist feels about your company can be the tiebreaker. So we measured it, and worked out why.
82
Oncologists
7
Companies scored
9
Attributes measured
82 oncologists · 7 companies · one score
Love Score spread: avg. across 7 APAC companies
- Promoters25%
- Passives53%
Inside the report
What We Found
We wanted to know how much oncologists love the pharma companies they work with, the key drivers behind those feelings, and what each one means for the actions you can take.
- Where you rank
- What drives it
- How to climb
What drives it
Nine Things Oncologists Judge You On
It's more than a scoreboard: it shows what earns an oncologist's love, and where you can earn more of it.
- Supports healthcare professionals beyond its medicines
- Engages oncologists as knowledgeable peers
- Has a clear point of view on improving healthcare
Driver importance
- Beyond the medicine18%
- Knowledgeable peers18%
In their words
What Oncologists Told Us
Half an hour is a big chunk of our day. Know what tumour types I treat, give me an agenda, and you'll get a much higher response rate.
Oncologist
Respects my time
Drug prices here are not like Europe. Without support programs, patients can't access global-standard treatments.
Oncologist
Patient access
Honestly, my relationship with those reps is probably what sways me, rather than the actual events I've gone to.
Oncologist
Relationship
Download
Get Your Love Score
Fill in your details to download the full report: “The Love Score: How APAC Oncologists Really Feel About Pharma, and What Earns Their Love.” This report is also available broken down by country, so select the market you want below, or choose the full pan-APAC version.